Korea
Gauss Labs and SK hynix Publish the Latest Results on AI-based Semiconductor Metrology Technology at SPIE AL 2024
- Two joint academic papers on AI-based metrology technology presented - Gauss Labs's innovative technology improves process control and equipment productivity in semiconductor manufacturing - Gauss Labs is at the forefront, leading industrial AI efforts to transform the manufacturing industr...
Lunit Presents Seven Study Results at ECR 2024: Showcasing AI's Robust Performance in Diverse Clinical Settings
- Lunit to unveil four oral presentations and three poster presentations at ECR 2024, highlighting Lunit INSIGHT's expansive capability, ranging from adaptability in different use cases to the potential to replace a human reader in mammography double-reading settings SEOUL, South Korea, Feb. 28...
STRADVISION Surpasses 1 Million Units in Annual Production, Leading the Charge in Automotive Vision Technology
SEOUL, South Korea, Feb. 26, 2024 /PRNewswire/ -- Building on the success of
its groundbreaking SVNet with 3D Perception Technology,STRADVISION
GC Cell and BioCentriq® Execute Process Transfer Agreement in Anticipation of the U.S. entry of Immuncell-LC Inj.
* Immuncell-LC Inj. is an autologous Cytokine Induced Killer (CIK) cell therapy approved for Commercial use inSouth Korea as an adjuvant cell therapy for the treatment of Hepatocellular Carcinoma (HCC) after curative resection and has receivedFDA Orphan Drug Designations (ODDs) for liver, brain...
SAPEON collaborates with DOCOMO Innovations for AI services enhancement
SAPEON collaborates with DOCOMO Innovations to conduct a PoC (Proof of Concept)
for providing AI services
SEOUL, South Korea, Feb. 26, 2024 /PRNewswire/ -- SAPEON (CEO Soojung Ryu,
www.sapeon.com
J INTS BIO, Phase 1/2 study of 'JIN-A02', a Novel Oral 4th Generation EGFR TKI, accepted for presentation at the upcoming American Association for Cancer Research 2024 meeting in USA (AACR 2024)
SEOUL, South Korea, Feb. 26, 2024 /PRNewswire/ -- J INTS BIO announced on the 26th of month that the Phase 1/2 clinical study of its Novel Oral 4th Generation EGFR TKI "JIN-A02" for the treatment of NSCLC has been accepted for poster presentation at the upcoming American Association for Cancer Re...
Flow Studio Takes Another Step Forward with CES 2024 Win
POHANG-SI, South Korea, Feb. 23, 2024 /PRNewswire/ -- Flow Studio
Oscotec/ADEL Initiates First-in-Human Dosing in Ph1 of Anti-MTBR Tau Antibody ADEL-Y01 In Alzheimer's Disease
PANGYO, South Korea, Feb. 23, 2024 /PRNewswire/ -- Oscotec Inc. and ADEL Inc. announced the dosing of the first healthy participant in its first-in-human study of ADEL-Y01 for the treatment of Alzheimer's disease (AD). Oscotec and ADEL are jointly developing a novel disease-modifying immunothera...
AUTOCRYPT Launches Cybersecurity Testing Platform for UN R155/156 and GB Compliance
New platform enables automotive OEMs to conduct regulatory compliant security testing and share integrated results for vehicle type approval SEOUL, South Korea, Feb. 20, 2024 /PRNewswire/ -- Automotive cybersecurity company AUTOCRYPT announced the launch of AutoCrypt CSTP, a comprehensive cybers...
Integrit Unveils 'Stella': Pioneering AI Hardware Generating Dynamic Interactions with LLMs
SEOUL, South Korea, Feb. 20, 2024 /PRNewswire/ -- AI Robotics platform
specialist Integrit (Seoul/integrit.ai
New Study Demonstrates Predictive Value of Lunit SCOPE IO to Predict Outcomes of Immune Checkpoint Inhibitor Therapy Across Diverse Tumors - published in the JITC
- A new study published in the Journal for ImmunoTherapy of Cancer (JITC) shows that Lunit's AI-powered biomarker "Lunit SCOPE IO" can predict favorable outcomes of Inflamed Immune Phenotype patients treated with Immune Checkpoint Inhibitor across multiple cancer types SEOUL, South Korea, Feb. ...
TelePIX Unveils TetraPLEX: A Breakthrough High-Performance AI Processor for Satellites
SEOUL, South Korea, Feb. 15, 2024 /PRNewswire/ -- TelePIX, a pioneering space startup based inSouth Korea, has achieved a groundbreaking feat: the development of TetraPLEX, a high-performance AI processor designed specifically for satellites. Boasting an impressive 10 trillion operations per seco...
STARmed to Accelerate Global Market Entry of EUSRA and ELRA Products through Olympus
SEOUL, South Korea, Feb. 14, 2024 /PRNewswire/ -- STARmed, a leading developer
and manufacturer of medical devices for tumor ablation, today announced global
market expansion of its EUSRA and ELRA products, throughOlympus
Sky Labs' CART BP Becomes the World's First to Complete Comparative Studies with All Blood Pressure Measurement Methods
- The only cuffless blood pressure monitor to complete comparative studies with three types of existing blood pressure measurement methods and prove even accuracy - 24-hour Ambulatory Blood Pressure Monitoring is the first pilot research to reflect ESH recommendations in 2023 SEOUL, South K...
GC Biopharma Presents Updates on its LSD Treatments at the WORLDSymposium 2024
* Recent updates on its development of LSD treatments were presented YONGIN, South Korea, Feb. 14, 2024 /PRNewswire/ -- GC Biopharma (CEO, Eun-Chul Huh), a South Korean biopharmaceutical company, announced onFeb. 14th that it has presented the development updates on its LSD (Lysosomal Storage D...
LG Energy Solution Strengthens Partnership with WesCEF, Secures Stable Lithium Supply Chain for the North American Market
* LG Energy Solution signs a second offtake agreement with WesCEF, expands its supply chain for competitive lithium procurement * Lithium hydroxide and lithium concentrate from WesCEF's Mt. Holland lithium project to be assembled into IRA-compliant batteries for the North American market * ...
STRADVISION Appoints Philip Vidal as Chief Business Officer to Drive Global Expansion
* Drawing from his roles at Motional and Tesla, Philip brings a wealth of
experience to his new position at STRADVISION SEOUL, South Korea, Feb. 12, 2024
/PRNewswire/ --STRADVISION
First in Human Dosed in Clinical Trial of ZMA001 for Treatment of Pulmonary Arterial Hypertension (PAH)
INCHEON, South Korea, Feb. 7, 2024 /PRNewswire/ -- Zymedi announced today that the first in human dosage of ZMA001, a monoclonal antibody being developed as a first-in-class treatment for Pulmonary Arterial Hypertension (PAH) has been initiated. The placebo-controlled phase 1 trial designed to a...
GC Labs successfully concludes day2 of Medlab Middle East 2024
YONGIN, South Korea, Feb. 6, 2024 /PRNewswire/ -- GC Labs, a leading clinical
laboratory inSouth Korea, announced that the company concluded day2 with a
successful performance at the Medlab Middle East 2024.
Amorepacific Announces Positive Research Results of Fermented Ginseng in Skin Lymphatic Activation
Reveals potential improvement in lymphatic activation and skin health through fermented ginseng ingredients SEOUL, South Korea, Feb. 6, 2024 /PRNewswire/ -- Amorepacific, in collaboration with the School of Mechanical Engineering at Korea University, has unveiled groundbreaking research demonstr...
Week's Top Stories
Most Reposted
TotalEnergies ENEOS Extends Solar Partnership with Ceres in Indonesia
[Picked up by 316 media titles]
2026-06-08 10:16DayOne Secures Over 1GW Renewable Energy in Malaysia in Landmark TNB Partnership
[Picked up by 303 media titles]
2026-06-04 23:55Amartha Initiates Coalition to Advance Financial Health for Grassroots Communities in Indonesia
[Picked up by 296 media titles]
2026-06-05 19:08DayOne Data Centers Announces Final Closing of its Series C Equity Financing at US$4.5 Billion
[Picked up by 294 media titles]
2026-06-05 15:00Omni HR Launches Mino, the First AI Agent Built on Unified APAC HR Data
[Picked up by 284 media titles]
2026-06-08 09:00